Robert Naclerio to Nasal Provocation Tests
This is a "connection" page, showing publications Robert Naclerio has written about Nasal Provocation Tests.
Connection Strength
5.120
-
Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul; 128(1):219-21.
Score: 0.387
-
Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc. 2008 Jan-Feb; 29(1):24-8.
Score: 0.310
-
Hot, humid air increases cellular influx during the late-phase response to nasal challenge with antigen. Clin Exp Allergy. 2001 Dec; 31(12):1913-22.
Score: 0.203
-
Warming of feet elevates nasal mucosal surface temperature and reduces the early response to nasal challenge with allergen. J Allergy Clin Immunol. 1999 Aug; 104(2 Pt 1):285-93.
Score: 0.173
-
Relationship between histamine and physiological changes during the early response to nasal antigen provocation. J Appl Physiol (1985). 1999 Feb; 86(2):659-68.
Score: 0.167
-
Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997 Oct; 100(4):505-10.
Score: 0.152
-
Effects of loratadine and terfenadine on the induced nasal allergic reaction. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):309-16.
Score: 0.136
-
Duration of action of intranasal atropine on methacholine-induced nasal secretions. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):321-3.
Score: 0.136
-
Lack of effect of hot, humid air on response to nasal challenge with histamine. Ann Otol Rhinol Laryngol. 1996 Feb; 105(2):146-54.
Score: 0.136
-
Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med. 1994 Jun; 149(6):1457-65.
Score: 0.121
-
The effect of terfenadine on unilateral nasal challenge with allergen. J Allergy Clin Immunol. 1994 Mar; 93(3):594-605.
Score: 0.119
-
Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine. Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):660-6.
Score: 0.119
-
Effects of antihistamines on inflammatory mediators. Ann Allergy. 1993 Sep; 71(3):292-5.
Score: 0.115
-
Unilateral nasal allergic reactions increase bilateral sinus eosinophil infiltration. J Appl Physiol (1985). 2013 Nov 01; 115(9):1262-7.
Score: 0.115
-
Effect of terfenadine on nasal provocation. Int Arch Allergy Immunol. 1993; 101(3):311-7.
Score: 0.110
-
Inhibition of mediator release during the early reaction to antigen. J Allergy Clin Immunol. 1992 Oct; 90(4 Pt 2):715-9.
Score: 0.108
-
The nasal response to histamine challenge: effect of the pollen season and immunotherapy. J Allergy Clin Immunol. 1992 Jul; 90(1):85-91.
Score: 0.106
-
Evidence of maxillary sinus inflammation in seasonal allergic rhinitis. Otolaryngol Head Neck Surg. 2012 Jun; 146(6):880-6.
Score: 0.103
-
Antigen-provoked increase in histamine reactivity. Observations on mechanisms. Am Rev Respir Dis. 1991 Sep; 144(3 Pt 1):642-8.
Score: 0.100
-
The effect of intranasal carbon dioxide on the acute response to nasal challenge with allergen. Allergy Asthma Proc. 2011 May-Jun; 32(3):206-12.
Score: 0.098
-
Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol. 1991 Apr; 87(4):855-66.
Score: 0.097
-
Localized antigen challenge of the nasal mucosa. Arch Otolaryngol Head Neck Surg. 1990 Dec; 116(12):1407-10.
Score: 0.095
-
Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol. 1990 Dec; 86(6 Pt 1):851-61.
Score: 0.095
-
Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis. 1990 Jun; 141(6):1428-33.
Score: 0.092
-
Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009 Jun; 123(6):1342-8.
Score: 0.085
-
Experimentally induced nasal allergic responses. J Allergy Clin Immunol. 1988 May; 81(5 Pt 2):940-9.
Score: 0.079
-
Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008 May; 121(5):1126-1132.e7.
Score: 0.079
-
Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988 Mar; 137(3):613-6.
Score: 0.078
-
Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):194-9.
Score: 0.078
-
Cold air-induced rhinitis. Clin Allergy Immunol. 2007; 19:267-81.
Score: 0.072
-
Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1986 Nov; 134(5):1102.
Score: 0.071
-
Effect of genetic background on the response to bacterial sinusitis in mice. Arch Otolaryngol Head Neck Surg. 2006 Oct; 132(10):1102-8.
Score: 0.071
-
Effects of intranasal azelastine on the response to nasal allergen challenge. Laryngoscope. 2002 Jan; 112(1):47-52.
Score: 0.051
-
Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med. 2001 Nov 26; 161(21):2581-7.
Score: 0.051
-
Natural and induced allergic responses increase the ability of the nose to warm and humidify air. J Allergy Clin Immunol. 2000 Dec; 106(6):1045-52.
Score: 0.047
-
A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol. 1997 Sep; 100(3):293-300.
Score: 0.038
-
Bilateral increases in histamine after unilateral nasal allergen challenge. Am J Respir Crit Care Med. 1997 Feb; 155(2):426-31.
Score: 0.036
-
Origin of late phase histamine release. J Allergy Clin Immunol. 1996 Oct; 98(4):721-3.
Score: 0.036
-
Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2. Clin Exp Allergy. 1996 Apr; 26(4):371-8.
Score: 0.034
-
Cold dry air-induced rhinitis: effect of inhalation and exhalation through the nose. J Appl Physiol (1985). 1995 Aug; 79(2):467-71.
Score: 0.033
-
Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action. Can J Physiol Pharmacol. 1995 Jul; 73(7):820-6.
Score: 0.033
-
In vivo human models for the study of anticholinergic drugs. J Allergy Clin Immunol. 1995 May; 95(5 Pt 2):1069-79.
Score: 0.032
-
The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage. Am J Respir Crit Care Med. 1995 Jan; 151(1):136-44.
Score: 0.031
-
Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 2):1303-9.
Score: 0.031
-
Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. Clin Exp Allergy. 1994 Mar; 24(3):288-90.
Score: 0.030
-
Effect of oxymetazoline on the early response to nasal challenge with antigen. J Allergy Clin Immunol. 1993 Nov; 92(5):767-70.
Score: 0.029
-
Demonstration of bilateral cholinergic secretory response after unilateral nasal cold, dry air challenge. Rhinology. 1993 Sep; 31(3):97-100.
Score: 0.029
-
Immunologic changes after nasal provocation with allergen. Otolaryngol Head Neck Surg. 1993 Sep; 109(3 Pt 2):579-83.
Score: 0.029
-
Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide. J Allergy Clin Immunol. 1992 Dec; 90(6 Pt 2):1051-4.
Score: 0.027
-
Local application of atropine attenuates the upper airway reaction to cold, dry air. Am Rev Respir Dis. 1992 Aug; 146(2):340-6.
Score: 0.027
-
Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. J Allergy Clin Immunol. 1992 Jun; 89(6):1065-75.
Score: 0.026
-
Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol. 1992 Jun; 89(6):1098-110.
Score: 0.026
-
The effect of azelastine on the early allergic response. Clin Exp Allergy. 1992 Feb; 22(2):289-95.
Score: 0.026
-
The impact of immunotherapy on the pathophysiology of ragweed pollen allergy. Rhinol Suppl. 1992; 14:52-6.
Score: 0.026
-
Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol. 1991 Jul; 88(1):27-32.
Score: 0.025
-
The role of leukotrienes in allergic rhinitis: a review. Am Rev Respir Dis. 1991 May; 143(5 Pt 2):S91-5.
Score: 0.024
-
Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis. 1991 Apr; 143(4 Pt 1):761-5.
Score: 0.024
-
Pharmacology of nasal provocation with bradykinin: studies of tachyphylaxis, cyclooxygenase inhibition, alpha-adrenergic stimulation, and receptor subtype. Int Arch Allergy Appl Immunol. 1991; 95(4):322-31.
Score: 0.024
-
Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen. Clin Exp Allergy. 1990 Nov; 20(6):701-5.
Score: 0.024
-
Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis. 1990 Jul; 142(1):167-71.
Score: 0.023
-
Responses to ragweed-pollen nasal challenge before and after immunotherapy. J Allergy Clin Immunol. 1989 Aug; 84(2):197-205.
Score: 0.022
-
In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis. 1988 Mar; 137(3):606-12.
Score: 0.020
-
Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11; 316(24):1506-10.
Score: 0.019
-
Arachidonic acid metabolites during nasal challenge. Arch Otolaryngol Head Neck Surg. 1987 Feb; 113(2):179-83.
Score: 0.018
-
Pharmacology of upper airways challenge. Int Arch Allergy Appl Immunol. 1987; 82(3-4):493-7.
Score: 0.018
-
Epithelial shedding is associated with nasal reactions to cold, dry air. J Allergy Clin Immunol. 2006 Jun; 117(6):1351-8.
Score: 0.017
-
The role of inflammatory mediators in allergic rhinitis. Ear Nose Throat J. 1986 May; 65(5):206-12.
Score: 0.017
-
Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy. 1986 Mar; 16(2):101-10.
Score: 0.017
-
Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002 Dec; 89(6):578-84.
Score: 0.014
-
Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction. Ann Allergy Asthma Immunol. 1997 Mar; 78(3):307-12.
Score: 0.009
-
Characterization of phospholipase A2 from human nasal lavage. Am J Respir Cell Mol Biol. 1994 Jul; 11(1):108-13.
Score: 0.008
-
Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy. 1990 Sep; 20(5):491-500.
Score: 0.006
-
Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol. 1989 Sep; 84(3):390-9.
Score: 0.005
-
Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol. 1989 Mar; 83(3):634-42.
Score: 0.005
-
Studies on the allergic and nonallergic nasal inflammation. J Allergy Clin Immunol. 1988 May; 81(5 Pt 1):782-90.
Score: 0.005
-
Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol. 1988 Mar; 81(3):580-9.
Score: 0.005
-
The effect of a histamine synthesis inhibitor on the immediate nasal allergic reaction. Allergy. 1987 Oct; 42(7):496-501.
Score: 0.005
-
Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis. J Immunol. 1986 Aug 15; 137(4):1323-8.
Score: 0.004
-
Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol. 1986 Aug 01; 137(3):977-82.
Score: 0.004
-
Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA. 1986 Jan 10; 255(2):225-9.
Score: 0.004
-
Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest. 1985 Dec; 76(6):2247-53.
Score: 0.004
-
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct; 76(4):1375-81.
Score: 0.004
-
Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol. 1985 Aug; 76(2 Pt 2):369-74.
Score: 0.004
-
Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest. 1985 Jul; 76(1):191-7.
Score: 0.004
-
Mediator release after allergic and physical nasal challenges. Int Arch Allergy Appl Immunol. 1985; 77(1-2):57-63.
Score: 0.004